Solasto (TSE:6197) Other Financing: 円-1,130 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6197 Solasto Corp TSE:6197
58 GF Score
Price 円1,110.00
GF Value 円564.61
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Solasto Other Financing?

Solasto TSE:6197 -0.09% 58 Other Financing is 円-1,130 Mil as of Mar. 2026. GuruFocus rates TSE:6197 with a GF Score™ of 58/100 and a GF Value™ of 円564.61 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Solasto's Other Financing for the three months ended in Mar. 2026 was 円-150 Mil.

Solasto's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was 円-1,130 Mil.


Solasto Other Financing Historical Data

* Premium members only.

The historical data trend for Solasto's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solasto Other Financing Chart

Solasto Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.00 -155.00 -3.00 -2.00 -3.00

Solasto Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -5.00 -519.00 -456.00 -150.00
TSE:6197
58GF Score
Solasto Corp TSE:6197
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solasto Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1,130 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of 円-1,130 Mil mean?
Solasto (TSE:6197) has a Other Financing of 円-1,130 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Solasto and its competitors.
Is Solasto's Other Financing too high?
Solasto's current Other Financing is 円-1,130 Mil. Overall, Solasto has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Solasto's Other Financing compare to HCA and THC?
Solasto's Other Financing of 円-1,130 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Solasto and its competitors. Solasto's current Other Financing is 円-1,130 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solasto stock overvalued right now?
Based on GuruFocus' analysis, Solasto (TSE:6197) is currently considered Significantly Overvalued. The stock's GF Value™ is 円564.61, compared to a current price of 円1,110.00 — trading 96.6% above its estimated fair value. The current Other Financing is 円-1,130 Mil. Solasto's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Solasto (TSE:6197), the current Other Financing is 円-1,130 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Solasto (TSE:6197) Overvalued in 2026?

Based on GuruFocus' analysis, Solasto stock appears to be overvalued. The current stock price of 円1,110.00 is trading 96.6% above its estimated GF Value™ of 円564.61. GuruFocus considers Solasto to be Significantly Overvalued.

Key valuation signals for TSE:6197:

  • Other Financing: 円-1,130 Mil
  • GF Value™: 円564.61 vs. price of 円1,110.00 (96.6% above fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the TSE:6197 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Solasto Business Description

Address 1-7-18 Konan, Minato-ku, Tokyo, JPN, 108-8210
Solasto Corp is engaged in providing medical outsourcing business, long-term care and child care business and others.
58GF Score

Get the complete analysis for TSE:6197

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,110.00
Price
円564.61
GF Value